Jensen Ackles talks the Darkness in Supernatural: 'We don't know the scope of her powers'


When it comes to big bads, the Winchester brothers have fought the best of them. From angry spirits to Lucifer himself, they know what it takes to...


Published on August 29, 2015 at 11:45PM

Shared at 1.71K shares/hour

Read More...

Comments

Post a Comment

Popular posts from this blog

Yu Founder On Next Flagship and Open Source Model for Upcoming Smartphones

Image
Micromax subsidiary Yu Televentures is gearing up to launch its next flagship smartphone this month. Ahead of the launch, company founder Rahul Sharma spoke to Gadgets 360 about the company's strategy for upcoming smartphones and the relationship with Cyanogen. He confirmed that the upcoming Yu flagship will run Android with some customisations from the company, and not Cyanogen , as seen on its predecessor. Sharma revealed that the company has so far sold 2 million devices since Yu established itself as an independent brand, with a new flagship smartphone expected to launch later this month. Talking about the upcoming smartphone, Sharma said that the company will be focusing on offering "pure Android experience" with a deep integration of Around Yu , a service aggregator platform that was introduced last year alongside the Yutopia flagship. He further hinted that the Around Yu will come with some new features. "When we got Cyanogen things were moving fine but ...
Read more

[In Depth] Scripps hooks prominent pair to lead it to health

Science: Current Issue The Scripps Research Institute has named two eminent scientists to lead one of the world's largest private biomedical research institutions. Scripps chemist Peter Schultz will serve as CEO, while Steve Kay, formerly a dean at the University of Southern California (USC), will serve as president. The announcement ends a contentious period between Scripps leadership and its faculty, who revolted a year ago when Scripps leaders attempted to merge the institute with USC. Schultz and Kay say they intend to marry the institute's historic strength in basic research with a new emphasis on translational research that aims to turn discoveries into medicines. If they succeed, the duo say, that should stabilize the institute's long-term finances. Author: Robert F. Service Read More...
Read more